AXGN | AxogenNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$49.50
-$0.35 (-0.70%)

Axogen (AXGN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Sep 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $49.50 vs 50 $42.85 / 200 $39.76
Projection
No cross projected
Test
No active test
Last cross
Golden cross 29 Sep 2025 ยท projected 25 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $49.37 vs 50 $38.21 / 200 $17.87
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 20 Jan 2025 ยท projected 29 bars out

Cross history

23
crosses on record since 2018
12 golden11 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
7 Oct 2026Death4-hour20 bars outNot tested
29 Sep 2025Golden steepdaily25 bars outNot tested
19 Aug 2025Golden4-hour30 bars outโ€”
30 May 2025Death steepdaily18 bars outNot tested
23 Apr 2025Death4-hour28 bars outโ€”

About AXGN

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$46.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.